fluorodeoxyglucose f18 has been researched along with Neoplasms, Nerve Sheath in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (25.00) | 29.6817 |
2010's | 21 (52.50) | 24.3611 |
2020's | 9 (22.50) | 2.80 |
Authors | Studies |
---|---|
Leng, X; Luo, J; Nie, J; Zeng, Y | 1 |
Anten, MHME; Broen, MPG; Geitenbeek, RTJ; Graven, LH; Martin, E; Taal, W; van der Pol, JAJ; Verhoef, C | 1 |
Chae, Y; Chang, D; Kang, BT; Kang, S; Kim, H; Koo, Y; Lee, D; Lee, H; Nam, H; Yang, MP; Yun, H; Yun, T | 1 |
Dong, Z; Guo, Z; Liu, W; Xie, P; Yang, L | 1 |
Das, JP; Riedl, CC; Ulaner, GA | 1 |
Bu, L; Feng, H; Tu, N | 1 |
Coert, JH; Geitenbeek, RTJ; Graven, LH; Grünhagen, DJ; Hanff, DF; Martin, E; Taal, W; Verhoef, C | 1 |
Ikuta, K; Imagama, S; Ito, K; Ito, S; Koike, H; Nishida, Y; Sakai, T; Urakawa, H | 1 |
Abdi, A; Eftekhari, M; Fallahi, B; Rakhshani, N; Saidi, B | 1 |
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
Cook, GJR; Ferner, R; Goh, V; Lovat, E; Siddique, M; Warbey, VS | 1 |
Kumar, R; Passah, A; Prashanth, A; Singhal, A; Tripathy, S | 1 |
Adam, G; Apostolova, I; Bannas, P; Derlin, T; Friedrich, RE; Herrmann, J; Mautner, VF; Salamon, J; Veldhoen, S; Yamamura, J | 1 |
Bredella, MA; Harris, GJ; Kassarjian, A; Lim, R; Merker, VL; Muzikansky, A; Plotkin, SR; Urban, T | 1 |
Derlin, T; Hagel, C; Mautner, VF | 1 |
Cichowski, K; DeRaedt, T; Fromm, JA; Ingraham, R; Maertens, O; Malone, CF | 1 |
Blakeley, JO; Chaudhry, M; Chirindel, A; Wahl, R | 1 |
Derlin, T; Friedrich, RE; Hagel, C; Mautner, VF; Salamon, J | 1 |
Adam, G; Derlin, T; Mautner, VF; Salamon, J | 1 |
Blay, JY; Brahmi, M; Combemale, P; Decouvelaere, AV; Mognetti, T; Pinson, S; Ranchere, D; Renard, C; Thiesse, P | 1 |
Adam, G; Apostolova, I; Derlin, T; Laqmani, A; Mautner, VF; Papp, L; Salamon, J; Tóth, Z | 1 |
Dry, SM; Eilber, FC; James, AW; Shurell, E; Singh, A | 1 |
Calonje, E; Dunn, JT; Ferner, RE; O'Doherty, MJ; Warbey, VS | 1 |
Harada, M; Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K | 1 |
Alavi, A; Bertagna, F; Biasiotto, G; Bosio, G; Giubbini, R; Rodella, C; Rosenbaum, J; Savelli, G | 1 |
Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Elashoff, D; Phelps, ME; Tap, WD; Weber, WA | 1 |
Guha, A; Hendler, A; Karabatsou, K; Kiehl, TR; Wilson, DM | 1 |
Amrami, KK; Esther, RJ; Lowe, VJ; Shahid, KR; Spinner, RJ | 1 |
Drubach, L; Fahey, F; Irons, M; Tsai, LL; Ullrich, NJ; Voss, S | 1 |
Baldwin, A; Derdak, J; Dombi, E; Gillespie, A; Kurwa, A; Meany, H; Reynolds, J; Salzer, W; Tsokos, M; Whatley, M; Widemann, B | 1 |
Derlin, T; Friedrich, RE; Gawad, K; Hagel, C; Zustin, J | 1 |
De Wever, W; Dooms, C; Van Zandweghe, L; Yserbyt, J | 1 |
Adam, G; Bannas, P; Bockhorn, M; Busch, JD; Derlin, T; Friedrich, RE; Hagel, C; Herrmann, J; Mautner, VF; Salamon, J | 1 |
Apostolova, I; Derlin, T; Friedrich, RE; Hagel, C; Mautner, VF; Münster, S; Tornquist, K; Wedegärtner, U | 1 |
Attigah, N; Cardona, S; Dimitrakopoulou-Strauss, A; Hinz, U; Lehnert, T; Mechtersheimer section sign, G; Schwarzbach, M | 1 |
Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Littrup, PJ; Taub, JW; Westphal, SM; Zak, IT; Zingas, AP | 1 |
Brenner, W; Buchert, R; Clausen, M; de Wit, M; Friedrich, RE; Gawad, KA; Hagel, C; Mautner, VF; von Deimling, A | 1 |
Calonje, E; Ferner, RE; Golding, JF; Jan, W; O'Doherty, M; Sanjayanathan, V; Smith, M | 1 |
Bingham, J; Cronin, BF; Ferner, RE; Hughes, RA; Lucas, JD; O'Doherty, MJ; Smith, MA | 1 |
Ferner, RE; Gutmann, DH | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Neoplasms, Nerve Sheath
Article | Year |
---|---|
A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
Topics: Bayes Theorem; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Topics: Adult; Cell Transformation, Neoplastic; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Malignant Peripheral Nerve Sheath Tumor.
Topics: Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2016 |
2 trial(s) available for fluorodeoxyglucose f18 and Neoplasms, Nerve Sheath
Article | Year |
---|---|
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
Topics: Adolescent; Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate | 2006 |
35 other study(ies) available for fluorodeoxyglucose f18 and Neoplasms, Nerve Sheath
Article | Year |
---|---|
Pelvic Plexiform Schwannoma on 18F-FDG PET/MRI.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Sheath Neoplasms; Neurilemmoma; Positron-Emission Tomography | 2022 |
Diagnostic value of
Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
18F-fluorodeoxyglucose positron emission tomography findings of peripheral nerve sheath tumour of the nasal cavity in a dog.
Topics: Animals; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Nasal Cavity; Nerve Sheath Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasms; Neoplasms, Second Primary; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography | 2023 |
18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor.
Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Sarcoma, Myeloid; Young Adult | 2020 |
Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Neoplasm Staging; Nerve Sheath Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Topics: Adolescent; Adult; Aged; Carcinogenesis; Child; Cross-Sectional Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; ROC Curve; Young Adult | 2021 |
FDG PET/CT of an Advanced Case of Malignant Nerve Sheath Tumor of Pleura.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Pleural Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Limit of Detection; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Antineoplastic Agents; Doxorubicin; Fluorodeoxyglucose F18; Humans; Male; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2014 |
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Whole Body Imaging; Young Adult | 2014 |
[Syndromic abdominal ganglioneuroma: a rare cause of false-positive findings in the F-18 FDG PET / CT in neurofibromatosis type 1].
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Ganglioneuroma; Humans; Intestinal Neoplasms; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers.
Topics: Antineoplastic Agents; Biomarkers; Class Ia Phosphatidylinositol 3-Kinase; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mechanistic Target of Rapamycin Complex 1; Molecular Targeted Therapy; Multiprotein Complexes; Neoplasms; Neoplasms, Nerve Tissue; Nerve Sheath Neoplasms; Neurofibromin 1; Positron-Emission Tomography; Protein Kinase Inhibitors; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Young Adult | 2015 |
Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1.
Topics: Abscess; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Male; Medical Errors; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Topics: Adolescent; Adult; Biopsy; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
Topics: Bone Neoplasms; Femur; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Nerve Sheath Neoplasms; Osteitis Fibrosa Cystica; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Positron-Emission Tomography; Radiopharmaceuticals; Thigh; Tomography, X-Ray Computed | 2009 |
Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nerves; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Tomography, X-Ray Computed; Young Adult | 2009 |
False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Topics: Adult; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2012 |
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
Topics: Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Membrane Glycoproteins; Mucin-1; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; S100 Proteins; Young Adult | 2012 |
EBUS-TBNA in the workup of a mediastinal mass.
Topics: Adult; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Nerve Sheath Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Biological Transport; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Topics: Adolescent; Adult; Child; Child, Preschool; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed; Young Adult | 2013 |
Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Retroperitoneal Neoplasms; S100 Proteins; Tomography, Emission-Computed | 2004 |
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Probability; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed | 2008 |
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Tomography, Emission-Computed | 2000 |
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Topics: Adolescent; Adult; Child; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1 | 2002 |